Haemodynamic and Antihypertensive Effect of Prostacyclin

  • A. Szczeklik
  • R. J. Gryglewski
  • J. Szczeklik
  • R. Nizankowski
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 164)


Prostacyclin (2) is a natural product of blood vessels, synthetized predominantly in endothelium and released in minute amounts into circulation (3). Besides its potent antiplatelet activity (1,4, 6), prostacyclin is also a powerful vasodilator. The vasodilating properties were noticed already during first administration of prostacyclin to man (7), and were subsequently studied in detail in 10 subjects without evidence of coronary heart disease or cardiac failure (11, 12). Prostacyclin was infused in three dose levels (2, 5 and 10 ng/kg/min) leading to following effects:
  1. 1)

    Distinct fall in peripheral and total pulmonary vascular resistances;

  2. 2)

    Drop in intra-arterial blood pressure;

  3. 3)

    Acceleration of the heart rate;

  4. 4)

    Increase in muscle blood flow;

  5. 5)

    Stroke volume, mean right atrial pressure and left ventricular end-diastolic pressure showed no significant changes.



Pulmonary Vascular Resistance Stroke VOlUME Index Muscle Blood Flow Arteriosclerosis Obliterans Precapillary Sphincter 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    R.J. Gryglewski, Prostaglandins, platelets and atherosclerosis. CRC Series in Biochemistry 7: 291 (1980).CrossRefGoogle Scholar
  2. 2.
    R.J. Gryglewski, S. Bunting, S. Moncada, R.J. Flower, J.R. Vane, Arterial walls are protected against deposition of platelet thrombi by a substance (Prostaglandin X) which they make from prostaglandins endoperoxides. Prostaglandins 12: 685 (1976).PubMedCrossRefGoogle Scholar
  3. 3.
    R.J. Gryglewski, R. Korbut, A. Ocetkiewicz, Generation of prostacyclin by lungs in vivo and its release into arterial circulation. Nature 273: 765 (1978).PubMedCrossRefGoogle Scholar
  4. 4.
    R.J. Gryglewski, A. Szczeklik, R. Nizankowski, Anti-platelet action of intravenous prostacyclin in man. Thrombos. Res. 13: 153 (1978).CrossRefGoogle Scholar
  5. 5.
    A. Ollson, L.A. Carlson, Clinical, haemodynamic and metabolic effects of intraarterial infusion of prostaglandin E1 in patients with peripheral vascular disease. Adv. Prostagl. Thrombox. Res. 1: 429 (1976).Google Scholar
  6. 6.
    A. Szczeklik, R.J. Gryglewski, E. Nizankowska, R. Nizankowski, J. Musial, Pulmonary and anti-platelet effects of intravenous and inhaled prostacyclin in man. Prostaglandins, 16: 651 (1978).CrossRefGoogle Scholar
  7. 7.
    A. Szczeklik, R.J. Gryglewski, R. Nizankowski, J. Musial, R. Pieton, J. Murk, Circulatory and antiplatelet effects of intravenous prostacyclin in healthy men. Pharmacol. Res. Commun. 10: 545 (1978).PubMedCrossRefGoogle Scholar
  8. 8.
    A. Szczeklik, R. Nizankowski, S. Skawinski, J. Szczeklik, P. Gluszko, R.J. Gryglewski, Succesful therapy of advanced arteriosclerosis obliterans with prostacyclin. Lancet 1: 1111 (1979).PubMedCrossRefGoogle Scholar
  9. 9.
    A. Szczeklik, J. Szczeklik, R. Nizankowski, P. Gluszko, Prostacyclin for unstable angina. N. Engl. J. Med. 303: 881 (1980).PubMedGoogle Scholar
  10. 10.
    J. Szczeklik, J.S. Dubiel, M. Mysik, Z. Pyzik, R. Krol, R. Horzela, Effects of prostaglandin E1 on pulmonary circulation in patients with pulmonary hypertension. Br. Heart J. 40: 1397 (1978).PubMedCrossRefGoogle Scholar
  11. 11.
    J. Szczeklik, A. Szczeklik, R. Nizankowski, Haemodynamic effects of prostacyclin in man. Adv. Prostagl. Thrombox. Res. 7: 769 (1980).Google Scholar
  12. 12.
    J. Szczeklik, A. Szczeklik, R. Nizankowski, Haemodynamic changes induced by prostayclin in man. Br. Heart J. 44: 254 (1980).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1984

Authors and Affiliations

  • A. Szczeklik
    • 1
  • R. J. Gryglewski
    • 1
  • J. Szczeklik
    • 1
  • R. Nizankowski
    • 1
  1. 1.Departments of Internal Medicine and PharmacologyCopernicus Academy of MedicineKrakowPoland

Personalised recommendations